glucagon-(Ser22Glu/Gln26Lys)
glucagon-(Ser22Glu/Gln26Lys)
| SMILES |
None |
| InChIKey |
None |
| Sequence |
HSQGTFTSDYSKYLDERRAEDFVKWLMNT |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Molecular weight (Da) |
|
Database connections
|
|
| Ligand site mutations |
GLP-1
|
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
glucagon-(Ser22Glu/Gln26Lys)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Database connections
|
|
| Ligand site mutations |
GLP-1
|
Sankey plot
Compound is not listed as a drug.